SCHEMBL7114196

SCHEMBL7114196

COc1ccc(-c2cccc(OCCC(C)CCCC(C)C)c2)cc1C(Cl)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALOX5 P09917 1/20 0.38
CTSA P10619 2/20 0.38
FDPS P14324 2/20 0.36
GAK O14976 1/20 0.36
GGPS1 O95749 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
ERN1 O75460 1/20 0.36
MAPK1 P28482 1/20 0.35
FFAR1 O14842 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
MGAM O43451 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858918 0.90 L3MBTL1 (0.40) MEN1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7114046 0.90 RARB (0.41) MEN1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5886067 0.88 ALOX5 (0.40) MEN1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7116628 0.87 FDPS (0.36) CYP1A2CYP2C9CYP2C19ALOX5FDPS
SCHEMBL13502288 0.84 FDPS (0.45) CYP1A2CYP2C9CYP2C19ALOX5FDPS
SCHEMBL7113738 0.83 FDPS (0.40) CYP1A2CYP2C9CYP2C19ALOX5CTSA
SCHEMBL7111616 0.82 TDP1 (0.37) ALOX5CTSAFDPSGGPS1TDP1
SCHEMBL27483201 0.81 LTA4H (0.46) ALOX5FDPSGGPS1FFAR1FFAR4
SCHEMBL6859293 0.80 RARB (0.43) MEN1KMT2AALOX5CTSAFDPS
SCHEMBL7201077 0.79 MEN1 (0.40) MEN1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6638646-B2 Polymerizing one or more monomers containing dihalogen containing substituted biaryls, via a base-induced dehydrohalogenation SEMICONDUCTORS GMBH (DE) 2003-10-28 US disclosed
US-20030088050-A1 Substituted poly(arylenevinylenes), process for their preparation, and their use in electroluminescent elements MERCK PATENT GMBH (DE) 2003-05-08 US disclosed
US-6509507-B2 Reacting a 6-membered aromatic ring with 1,4- position ester or benzylic OH groups with a second aromatic in a palladium catalyzed cross-coupling; electroluminescence AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2003-01-21 US disclosed
US-20020087030-A1 Polymerizable biaryls, process for their preparation and their use MERCK PATENT GMBH (DE) 2002-07-04 US disclosed
US-20020064680-A1 Substituted poly(arylene vinylenes), method for producing the same, and their use in electroluminescent elements AXIVA GMBH (DE) 2002-05-30 US disclosed
US-6323373-B1 USED TO OBTAIN POLYMERS WHICH ARE USED AS ELECTROLUMINESCENCE MATERIALS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020087030-A1 Polymerizable biaryls, process for their preparation and their use PAH, TYR, PAICS MEN1 3893/4885CYP1A2 99/4885CYP3A4 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.